Latest stories on IMCR
Immunocore Holdings plc (IMCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Immunocore Completes Enrollment in Phase 3 Melanoma Trial
TipRanks63 · neutralproduct/pr
Immunocore achieves target patient enrollment in TEBE-AM clinical trial
The Fly67 · bullishproduct/pr
Immunocore Holdings plc (IMCR) files 8-K
SEC 8-K50 · neutralgeneral
Immunocore to present at upcoming investor conferences
GlobeNewswire56 · neutralgeneral
Immunocore to present at upcoming investor conferences
Business Insider56 · neutralgeneral
Immunocore reinstated with an Overweight at JPMorgan
The Fly63 · neutralanalyst
Immunocore Price Target Raised To 43 From 40 At Morgan Stanley
The Fly61 · neutralanalyst
Immunocore Holdings plc 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year
Seeking Alpha63 · neutralproduct/pr
Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Immunocore Q2 Earnings Call Highlights
Yahoo Finance65 · bullishearnings
Immunocore Holdings plc (IMCR) files 8-K
SEC 8-K50 · neutralgeneral
Immunocore reports second quarter financial results and provides a business update
Business Insider55 · neutralearnings
Immunocore Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
Business Insider50 · neutralgeneral
Immunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR Platform
Seeking Alpha67 · bullishproduct/pr
Is Immunocore Holdings (IMCR) One of the Best Small Cap Stocks to Buy for the Long Term?
Yahoo Top57 · neutralanalyst
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma | IMCR Stock News
StockTitan69 · bullishproduct/pr